SCR-4026

N/A

Report date: 2023/09/18 09:19:29
NME

Base Information

Drug NameSCR-4026
Drug Alias NameSCR-4026
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuronal nitric oxide synthase and Postsynaptic density protein-95 interaction inhibitor
TargetsDisks large homolog 4Nitric oxide synthase
Therapy Area/IndicationsStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesNanjing Simcere Dongyuan Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNanjing Simcere Dongyuan Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsStroke
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A